Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $88.88 million. The enterprise value is $92.22 million.
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BMGL has 18.46 million shares outstanding.
| Current Share Class | 18.46M |
| Shares Outstanding | 18.46M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.89% |
| Owned by Institutions (%) | 55.13% |
| Float | 5.72M |
Valuation Ratios
The trailing PE ratio is 48.41.
| PE Ratio | 48.41 |
| Forward PE | n/a |
| PS Ratio | 9.96 |
| Forward PS | n/a |
| PB Ratio | 13.27 |
| P/TBV Ratio | 16.05 |
| P/FCF Ratio | 48.08 |
| P/OCF Ratio | 48.35 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 57.62, with an EV/FCF ratio of 49.54.
| EV / Earnings | 60.31 |
| EV / Sales | 12.41 |
| EV / EBITDA | 57.62 |
| EV / EBIT | 58.43 |
| EV / FCF | 49.54 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.76.
| Current Ratio | 2.26 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 2.14 |
| Debt / FCF | 2.26 |
| Interest Coverage | 12.14 |
Financial Efficiency
Return on equity (ROE) is 31.77% and return on invested capital (ROIC) is 10.29%.
| Return on Equity (ROE) | 31.77% |
| Return on Assets (ROA) | 8.44% |
| Return on Invested Capital (ROIC) | 10.29% |
| Return on Capital Employed (ROCE) | 23.39% |
| Revenue Per Employee | $232,149 |
| Profits Per Employee | $47,783 |
| Employee Count | 32 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 70.66 |
Taxes
In the past 12 months, BMGL has paid $244,732 in taxes.
| Income Tax | 244,732 |
| Effective Tax Rate | 13.80% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 69.42 |
| Average Volume (20 Days) | 123,663 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BMGL had revenue of $7.43 million and earned $1.53 million in profits. Earnings per share was $0.09.
| Revenue | 7.43M |
| Gross Profit | 3.09M |
| Operating Income | 1.58M |
| Pretax Income | 1.87M |
| Net Income | 1.53M |
| EBITDA | 1.60M |
| EBIT | 1.58M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $1.51 million in cash and $4.21 million in debt, giving a net cash position of -$2.71 million or -$0.15 per share.
| Cash & Cash Equivalents | 1.51M |
| Total Debt | 4.21M |
| Net Cash | -2.71M |
| Net Cash Per Share | -$0.15 |
| Equity (Book Value) | 5.58M |
| Book Value Per Share | 0.34 |
| Working Capital | 6.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.85 million and capital expenditures -$5,842, giving a free cash flow of $1.86 million.
| Operating Cash Flow | 1.85M |
| Capital Expenditures | -5,842 |
| Free Cash Flow | 1.86M |
| FCF Per Share | $0.10 |
Full Cash Flow StatementMargins
Gross margin is 41.54%, with operating and profit margins of 21.24% and 20.58%.
| Gross Margin | 41.54% |
| Operating Margin | 21.24% |
| Pretax Margin | 23.88% |
| Profit Margin | 20.58% |
| EBITDA Margin | 21.54% |
| EBIT Margin | 21.24% |
| FCF Margin | 25.06% |